June 11, 2026 IGC Pharma Reaches Previously Disclosed 146-Patient Enrollment Target in Phase 2 CALMA Trial, Advancing Toward Topline Analysis
June 11, 2026 VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership
June 11, 2026 How Machine Learning Is Quietly Reshaping One of International Trade’s Oldest Bottlenecks
